On September 25, 2017, the FDA and lupus patients came together for a historic patient-focused drug development meeting.
New population-based analyses measure incidence and prevalence of lupus among these fast growing U.S. populations.
This new research program provides $5 million that will greatly expand the number of lupus-specific research studies that can be supported through the DoD.
For years, our Health Educators have received feedback from people with lupus about wanting a place where they can connect with others and receive support without having to leave their homes.
LupusConnect brings together people impacted by lupus to share experiences and find timeless support.
Before joining Team Make Your Mark, Danica had never run more than five miles. Crossing the finish line in Seattle left her feeling truly connected to the lupus community.
We're working to ensure that the new funding is directed to research projects that can make the most difference.
Benlysta SC is the first self-injection lupus treatment that can administered at home once per week.